MedTrace Logo

Dispensing Study for a New Study Lens

NCT02642991 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2020-12-01

Study results available
· View outcomes & findings →

Summary

This study investigated the performance criteria over one week of daily wear to determine if the comfilcon A asphere lens (test) performed equivalently to the comfilcon A sphere (control) in terms of measurement and subjective ratings of visual performance.

Conditions

  • Myopia

Interventions

DEVICE

Phenacite

contact lens

DEVICE

comfilcon A

contact lens

Sponsors & Collaborators

  • CooperVision, Inc.

    lead INDUSTRY

Principal Investigators

  • Lyndon Jones · CCLR, University of Waterloo

  • Pete Kollbaum, OD, PhD · CORL, Indiana University

  • Meng Lin, OD, PhD · CRC, University of California, Berkeley

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2016-01-31
Completion
2016-03-31
FDA Device
Yes

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02642991 on ClinicalTrials.gov